Histological and molecular sub types of ovarian cancer

Development of clinical trials and biobanks

The AKT pathway and chemotherapy resistant ovarian cancer

Ovarian cancer tumour banks and collaboration

Interplay between pathologies of ovarian cancer and genomics

Biology of molecular sub types in ovarian cancer

Sub-typing ovarian cancer

Early stage biomarkers in ovarian cancer

Interaction between tumour biology and surgery

Collaborations in clinical trials to bring new drugs to patients earlier

Inequalities in cancer incidence, mortality and survival

Development of future cancer treatments